Take action now.

If you wish to help people with MS get the medicines they need, you can send an email to the Minister for Health and general election candidates in your constituency to highlight your concerns. Why not make your voice heard by asking them to fix the issue facing thousands of people with MS and their loved ones? Demand quick access for new MS medicines. For your convenience, you can use the below system.

1. Select your constituency

2. Fill in your details

3. Edit the email to reflect your views and experience.

4. Send

Fill in your details below to send this email to the Minister for Health and general election candidates in your constituency

Determine what constituency you are in. Search by address, or click “Automatically determine my location” if you’re accessing this page from home.

Dear Candidate,

Edit the email to reflect your views

[Your name and constituency will be auto inserted at the end of the email]

1 http://oireachtasdebates.oireachtas.ie/Debates%20Authoring/DebatesWebPack.nsf/committeetakes/HEJ2017092700002?opendocument

2 http://www.ipha.ie/news-events/latest-news/news/ipha-guidance-on-direct-healthcare-professiona-(6)

3 National Centre for Pharmacoeconomics http://www.ncpe.ie

4 EFPIA W.A.I.T Indicator 2016, http://www.ipha.ie/getattachment/Publications-Submissions/IPHA-publications/New-medicines-for-patients-as-fast-as-in-Europe.pdf.aspx, pg 8.

5 QuintilesIMS, MIDAS, March 2017, http://www.ipha.ie/getattachment/News-Events/Latest-News/News/IPHA-Guidance-on-Direct-Healthcare-Professiona-(2)/Access-infographic-(1).pdf.aspx

6 QuintilesIMS, MIDAS Mar 2017; the measure is recorded sales; GR and LU retail only; % represent the number of New Active Substances launched. http://www.ipha.ie/getattachment/Publications-Submissions/IPHA-publications/New-medicines-for-patients-as-fast-as-in-Europe.pdf.aspx

7 http://ms-society.ie/pages/living-with-ms/what-is-ms

8 https://www.roche.com/dam/jcr:49f64258-d904-45df-a3ef-d3b2b544c409/en/understanding_ms.pdf

The content of the e-mail sent through this website is known solely to its recipient. It is not monitored by Roche Products (Ireland)  Limited or any other third party. This e-mail is not intended for adverse event reporting purposes. Should you wish to report any adverse event that may have occurred with a Roche medicine, you can contact at your convenience either Roche Products (Ireland) Limited Pharmacovigilance department: ireland.drug_surveillance_centre@roche.com or connect to the HPRA website: https://www.hpra.ie/homepage/about-us/report-an-issue/human-adverse-reaction-form